-+ 0.00%
-+ 0.00%
-+ 0.00%

KALVISTA PHARMACEUTICALS ANNOUNCES APPROVAL OF EKTERLY® (SEBETRALSTAT) IN JAPAN, FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

Reuters·12/22/2025 11:00:00

Please log in to view news